1. Home
  2. HCTI vs BIVI Comparison

HCTI vs BIVI Comparison

Compare HCTI & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCTI

Healthcare Triangle Inc.

HOLD

Current Price

$0.66

Market Cap

11.4M

Sector

Technology

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.57

Market Cap

10.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCTI
BIVI
Founded
2020
2013
Country
United States
United States
Employees
58
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4M
10.3M
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
HCTI
BIVI
Price
$0.66
$1.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.6M
303.0K
Earning Date
04-16-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 74.83
EPS
N/A
★ N/A
Revenue
★ $13,891,000.00
N/A
Revenue This Year
$79.33
N/A
Revenue Next Year
$20.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 18.77
N/A
52 Week Low
$0.14
$0.82
52 Week High
$9.97
$3.79

Technical Indicators

Market Signals
Indicator
HCTI
BIVI
Relative Strength Index (RSI) 37.66 40.36
Support Level $0.14 $1.18
Resistance Level $1.01 $1.76
Average True Range (ATR) 0.23 0.14
MACD 0.02 -0.05
Stochastic Oscillator 1.24 1.67

Price Performance

Historical Comparison
HCTI
BIVI

About HCTI Healthcare Triangle Inc.

Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their efforts to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Corporate & others.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: